George Hardman, MD
Psychiatry · Franklin, MANPI 1629047774
Payments from drug & device makers
Across 27 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$136
- Neurocrine Biosciences, Inc.$89
- Johnson & Johnson$87
- Alkermes, Inc.$48
- Sunovion Pharmaceuticals Inc.$37
- Ironshore Pharmaceuticals Inc.$33
- plus $73 from 3 others
What the payments were for
- Food & beverage$503100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $136 |
| Neurocrine Biosciences, Inc. | 4 | $89 |
| Johnson & Johnson | 5 | $87 |
| Alkermes, Inc. | 3 | $48 |
| Sunovion Pharmaceuticals Inc. | 3 | $37 |
| Ironshore Pharmaceuticals Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $22 |
| Shire North American Group Inc | 1 | $22 |
How this compares
$505 in reported general payments places this provider in the 75th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 189 | $30,065 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 170 | $29,024 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 710 | $22,388 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 28 | $21,005 |
| AmbienZolpidem Tartrate | 14 | $13,844 |
| Oxcarbazepine | 221 | $8,900 |
| Clonazepam | 865 | $8,657 |
| Adderall XrDextroamphetamine/Amphetamine | 19 | $7,583 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 84 | $5,569 |
| Alprazolam | 410 | $5,363 |
| Clozapine | 23 | $4,732 |
| Divalproex Sodium | 39 | $4,707 |
| Bupropion Hcl SrBupropion Hcl | 254 | $4,603 |
| Lurasidone Hcl | 28 | $4,532 |
| Quetiapine Fumarate | 253 | $4,362 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Franklin
- Lee CohenBoston$7M
- Dyanna DomiliciBoston$5.8M
- Arkadiy StolyarBelmont$3.3M
- Maurizio FavaBoston$2.8M
- Marc ShayAmesbury$1.7M
- Martha StarkNewton$1.6M
- Hadine JoffeBoston$1.5M
- Malini NairWinchester$1M
- Xiaoduo FanWorcester$950K
- Anthony RothschildWorcester$838K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.